Abstract
A major problem in the chemotherapy of colorectal cancers is their resistance to most cytotoxic drugs which may be due to insufficient cellular transport. Drugs conjugated to monoclonal antibodies recognising tumour antigens may overcome these difficulties by providing access of active agents to the tumour cells. The anti-tumour monoclonal antibody shown to localise in patients with colorectal cancer, 791T/36, has been investigated as a potential targeting antibody. Eight cell lines were established from surgically resected material and were shown to bind 791T/36 antibody. They were screened for their sensitivity to methotrexate, 5-fluorouracil and daunomycin. Although 5-fluorouracil is the drug of choice for chemotherapy of colorectal cancer it was the most cytotoxic drug in only 2 of the 8 cell lines. Only the 4 cell lines which were resistant to methotrexate showed less cytotoxicity with methotrexate than 5-fluorouracil. The cell lines which were resistant to methotrexate were more sensitive to 791T/36-methotrexate conjugates. Daunomycin was the most cytotoxic drug in 4 of the 8 cell lines. However, a similar cytotoxicity was observed for free drug and 791T/36 daunomycin in the two lines tested. Selective monoclonal antibody drug conjugates may offer a solution to treatment of tumours which are resistant to classical chemotherapeutic agents. This is the first report to show that newly established cell lines that are resistant to classical chemotherapeutic agents are rendered sensitive when the drug enters the cell as a drug monoclonal antibody carrier.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Durrant, L., Garnett, M., Gallego, J. et al. Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates. Br J Cancer 56, 722–726 (1987). https://doi.org/10.1038/bjc.1987.277
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.277
This article is cited by
-
Internalization of an intact doxorubicin immunoconjugate
Cancer Immunology Immunotherapy (1994)
-
Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice
Cancer Immunology Immunotherapy (1992)
-
Antibody-directed therapy of multidrug-resistant tumor cells
Medical Oncology and Tumor Pharmacotherapy (1992)
-
Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice
Cancer Immunology Immunotherapy (1990)
-
Inhibition of protein synthesis, pulmonary localization and pulmonary tumour formation by drug-treated tumour cells as a means of predicting their chemosensitivity
Clinical & Experimental Metastasis (1989)